questionsmedicales.fr
Tumeurs
Tumeurs par siège
Tumeurs du thorax
Tumeurs du thorax : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tumeurs thoraciques
Biopsie
Imagerie médicale
Tomodensitométrie
IRM
Bronchoscopie
Marqueurs tumoraux
Tumeurs thoraciques
Suivi médical
Histologie
Tumeurs thoraciques
Diagnostic
Tests génétiques
Tumeurs thoraciques
Traitement ciblé
Symptômes
5
Symptômes
Tumeurs thoraciques
Essoufflement
Perte de poids
Tumeurs thoraciques
Symptômes
Hémoptysie
Tumeurs thoraciques
Symptômes
Fatigue
Tumeurs thoraciques
Symptômes
Types de tumeurs
Tumeurs thoraciques
Symptômes
Prévention
5
Prévention
Tabagisme
Agents cancérigènes
Dépistage
Tumeurs thoraciques
Prévention
Alimentation
Prévention
Tumeurs thoraciques
Exercice physique
Prévention
Tumeurs thoraciques
Vaccination
Prévention
Cancers
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Tumeurs thoraciques
Stade de la maladie
Chimiothérapie
Tumeurs thoraciques
Traitement néoadjuvant
Radiothérapie
Tumeurs thoraciques
Traitement complémentaire
Thérapies ciblées
Tumeurs thoraciques
Traitement
Complications
5
Complications
Métastase
Insuffisance respiratoire
Douleur thoracique
Tumeurs thoraciques
Complications
Difficultés respiratoires
Tumeurs thoraciques
Complications
Thrombose
Tumeurs thoraciques
Complications
Complications post-chirurgicales
Tumeurs thoraciques
Chirurgie
Facteurs de risque
5
Facteurs de risque
Tabagisme
Amiante
Âge
Facteurs de risque
Tumeurs thoraciques
Antécédents médicaux
Facteurs de risque
Tumeurs thoraciques
Exposition professionnelle
Facteurs de risque
Tumeurs thoraciques
Mode de vie
Facteurs de risque
Tumeurs thoraciques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du thorax : Questions médicales les plus fréquentes",
"headline": "Tumeurs du thorax : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du thorax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-21",
"dateModified": "2025-03-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs par siège",
"url": "https://questionsmedicales.fr/mesh/D009371",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs par siège",
"code": {
"@type": "MedicalCode",
"code": "D009371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome pulmonaire",
"alternateName": "Adenocarcinoma of Lung",
"url": "https://questionsmedicales.fr/mesh/D000077192",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D000077192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome bronchioloalvéolaire",
"alternateName": "Adenocarcinoma, Bronchiolo-Alveolar",
"url": "https://questionsmedicales.fr/mesh/D002282",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome bronchioloalvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D002282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Blastome pulmonaire",
"alternateName": "Pulmonary Blastoma",
"url": "https://questionsmedicales.fr/mesh/D018202",
"about": {
"@type": "MedicalCondition",
"name": "Blastome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D018202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.867"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"alternateName": "Solitary Fibrous Tumor, Pleural",
"url": "https://questionsmedicales.fr/mesh/D054363",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"code": {
"@type": "MedicalCode",
"code": "D054363",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.640.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax",
"alternateName": "Thoracic Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D013899",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan Wang",
"url": "https://questionsmedicales.fr/author/Yan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China."
}
},
{
"@type": "Person",
"name": "Naseema Gangat",
"url": "https://questionsmedicales.fr/author/Naseema%20Gangat",
"affiliation": {
"@type": "Organization",
"name": "Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Anja C Roden",
"url": "https://questionsmedicales.fr/author/Anja%20C%20Roden",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."
}
},
{
"@type": "Person",
"name": "Marianne Pavel",
"url": "https://questionsmedicales.fr/author/Marianne%20Pavel",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University Hospital Erlangen, Erlangen, Germany."
}
},
{
"@type": "Person",
"name": "Dermot O'Toole",
"url": "https://questionsmedicales.fr/author/Dermot%20O%27Toole",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cardiopulmonary Bypass Emergencies and Intraoperative Issues.",
"datePublished": "2022-07-14",
"url": "https://questionsmedicales.fr/article/36100499",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.jvca.2022.07.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy.",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37697290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13019-023-02359-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of cardiopulmonary bypass on plasma and erythrocytes oxylipins.",
"datePublished": "2023-08-29",
"url": "https://questionsmedicales.fr/article/37644527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12944-023-01906-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adverse renal effects associated with cardiopulmonary bypass.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36794518",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/02676591231157055"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lung injury following cardiopulmonary bypass: a clinical update.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36408601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14779072.2022.2149492"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par siège",
"item": "https://questionsmedicales.fr/mesh/D009371"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du thorax",
"item": "https://questionsmedicales.fr/mesh/D013899"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du thorax - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du thorax",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du thorax",
"description": "Comment diagnostiquer une tumeur thoracique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés aux tumeurs thoraciques ?\nQuelle est l'importance de l'histologie ?\nLes examens génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du thorax",
"description": "Quels sont les symptômes courants des tumeurs thoraciques ?\nLa perte de poids est-elle un symptôme ?\nLes tumeurs thoraciques causent-elles des saignements ?\nComment la fatigue se manifeste-t-elle ?\nLes symptômes varient-ils selon le type de tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du thorax",
"description": "Comment prévenir les tumeurs thoraciques ?\nLe dépistage est-il utile ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il à prévenir ?\nLes vaccinations sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du thorax",
"description": "Quels traitements sont disponibles pour les tumeurs thoraciques ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que la chimiothérapie néoadjuvante ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du thorax",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs thoraciques peuvent-elles causer des douleurs ?\nComment les tumeurs affectent-elles la respiration ?\nLes tumeurs peuvent-elles provoquer des caillots sanguins ?\nQuelles sont les complications post-chirurgicales ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du thorax",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Cardiopulmonary+Bypass#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une tumeur thoracique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la tomodensitométrie, l'IRM et la bronchoscopie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux tumeurs thoraciques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme le CEA et le CA 125 peuvent être utilisés pour le suivi."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histologie permet de déterminer le type de tumeur et son agressivité."
}
},
{
"@type": "Question",
"name": "Les examens génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à identifier des mutations spécifiques pour le traitement ciblé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs thoraciques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux persistante, la douleur thoracique et l'essoufflement."
}
},
{
"@type": "Question",
"name": "La perte de poids est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de poids inexpliquée peut être un signe de tumeur thoracique."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des hémoptysies, c'est-à-dire des saignements dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut être persistante et s'aggraver avec l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les tumeurs thoraciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et l'exposition à des agents cancérigènes aide à prévenir."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs thoraciques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie dépend du stade et de la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la chimiothérapie néoadjuvante ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement administré avant la chirurgie pour réduire la taille de la tumeur."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter les tumeurs non opérables ou en complément."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies ciblées sont disponibles pour certains types de tumeurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la métastase, l'infection et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques peuvent-elles causer des douleurs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs thoraciques dues à la pression sur les nerfs."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la respiration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent obstruer les voies respiratoires, entraînant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles provoquer des caillots sanguins ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications post-chirurgicales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des saignements et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à l'amiante et les antécédents familiaux sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de tumeurs thoraciques augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer augmentent le risque de développer des tumeurs thoraciques."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des substances cancérigènes, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Publications dans "Tumeurs du thorax" :
3 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University Hospital Erlangen, Erlangen, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University of Cologne, Cologne, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany. hm.kvasnicka@patho-uwh.de.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Mainz 55131, Germany.
Joint Unit Immunopathology, Institute of Pathology, University Medical Center, JGU-Mainz and TRON, Translational Oncology at the University Medical Center, JGU-Mainz, Mainz 55131, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Haematology, Queen's University, Belfast, United Kingdom.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eskisehir City Hospital, Eskisehir, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
Cardiopulmonary bypass (CPB) is a complex biomechanical engineering undertaking and an essential component of cardiac surgery. However, similar to all complex bioengineering systems, CPB activities ar...
Hypersensitivity reactions to heparin are uncommon conditions but pose a serious clinical problem for patients requiring cardiopulmonary bypass. Bivalirudin is a reversible direct thrombin inhibitor t...
A 49-year-old male patient was admitted to our hospital for coronary artery bypass graft operation with mitral insufficiency and tricuspid valve insufficiency. Heparin allergy was confirmed by skin bi...
Alternative anticoagulation strategies are needed for cardiopulmonary bypass in patients unable to use heparin. Bivalirudin may be recommended as a viable alternative anticoagulant in patients with he...
Oxylipins, the oxidative metabolites of polyunsaturated fatty acids (PUFAs), serve as key mediators of oxidative stress, inflammatory responses, and vasoactive reactions in vivo. Our previous work has...
We conducted a prospective observational study of 12 patients undergoing elective cardiac surgery with expected CPB procedure. We collected venous and arterial blood samples before CPB, 15 and 45 min ...
Our results revealed that most venous plasma diols and hydroxy- oxylipins decreased after CPB initiation, with a continuous decline until the termination of CPB. Nevertheless, no statistically signifi...
CPB decreases numerous diols and hydroxy oxylipins in blood plasma, whereas no changes in erythrocytes oxylipins are observed during this procedure in patients undergoing cardiac surgery. As lipid med...
Cardiac surgery on cardiopulmonary bypass (CPB) is associated with postoperative renal dysfunction, one of the most common complications of this surgical cohort. Acute kidney injury (AKI) is associate...
Cardiopulmonary bypass (CPB) is an integral component of cardiac surgery; however, one of its most critical complications is acute lung injury induced by multiple factors including systemic inflammato...
The objective of this review is to investigate the multiple factors that can lead to CPB-induced lung injury. These include contact of blood components with the artificial surface of the CPB circuit, ...
Although many aspects of CPB are proposed to contribute to lung injury, its overall role is still not clear. Multiple interventions have been introduced to reduce the risk of pulmonary dysfunction, wi...
The safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the pe...
Cardiopulmonary bypass generates an exacerbated response that may lead to sepsis....
To describe the association between procalcitonin levels and sepsis diagnosis in cardiovascular surgery subjects with cardiopulmonary bypass....
A case-series study was conducted in 142 patients. Serum procalcitonin levels were measured at 24 hours and at 72 hours after surgery using a point of care testing based on quantitative immunochromato...
From 142 patients studied, 7 developed sepsis after surgery (4.9%). For 24-hours procalcitonin levels AUC was 0.921 and best cut-off point was 3.8 ng/mL (sensitivity 0.857 and specificity 0.904). In t...
Procalcitonin levels at 24 and 72 hours after cardiovascular surgery with cardiopulmonary bypass are associated with sepsis presence at cut-off points of 3.8 and 8.4 ng/mL respectively....
This study aims to assess the risk factors for insufficient vancomycin concentrations for its prophylactic use in adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to mod...
The aim of this study was to assess the reproducibility of the new viscoelastic analyzer ClotPro, and compare the parameters this system produces with the ROTEM delta system in patients undergoing car...
A prospective and observational study....
At a university hospital....
Forty adult patients undergoing cardiac surgery with CPB....
Correlations were calculated between ClotPro and ROTEM delta parameters....
The ClotPro showed a high reproducibility in most of the parameters of each test; whereas ROTEM delta, although showing a low coefficient of variation in the parameters related to clot firmness, showe...
ClotPro can be used as an alternative to ROTEM delta to evaluate coagulation function in cardiac surgery, but specific reference ranges need to be established first....
Pulmonary hypertension (PH) is frequently associated with cardiovascular surgery and is a common complication that has been observed after surgery utilizing cardiopulmonary bypass (CPB). The purpose o...
The PubMed database was utilized to find published articles....
There are many mechanisms that contribute to PH after cardiac surgery and CPB which involve pulmonary vasomotor dysfunction, cyclooxygenase, the thromboxane A2 and prostacyclin pathway, the nitric oxi...
By possessing a deep understanding of the mechanisms that contribute to PH after cardiac surgery and CPB, researchers can develop treatments for clinicians to use which target the mechanisms of PH and...